Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,123.32
(
0.84%
)
US TECH 100
26,148.60
(
1.46%
)
Dow Jones
49,381.47
(
-0.13%
)
Brent Oil
96.83
(
1.92%
)
Bitcoin
79,060.65
(
3.58%
)
News Focus
News Focus
Post# of 445413
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 590
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: dr_lowenstein post# 112727

Friday, 06/13/2014 10:38:40 AM

Friday, June 13, 2014 10:38:40 AM

Post# of 445413
Purdue was smart enough NOT to pursue a 1-bead Embeda whereas Pfizer/King/Alparma were not. So now opportunistic Purdue after many years of "bad guy" image with Oxycontin is suddenly trying to portray the White Knight image with Hydrocodone. Alas Purdue remains the Black Knight fooling no one with its easily defeated physical barrier opioid drugs.


$ELTP with its triple patented Pharmacological ADTs ELI200/201/202/216 are the answers that the FDA wants.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News